The Fetal Medicine Foundation 16th World Congress in Fetal Medicine, Ljubljana, Slovenia
Abstracts
 
  • Aneuploidies
  • cfDNA test
  • Defects
    • CNS
    • Face
    • High NT
    • Heart
    • Lungs
    • Gastrointestinal
    • Kidney
    • Skeleton
    • Tumors
    • Placenta
    • Syndromes
    • Other
    • All
  • Fetal therapy
  • Impaired placentation
  • GDM / Obesity
  • Preterm birth
  • Congenital infections
  • Labor / Delivery
  • Maternal conditions
  • Multiple pregnancies
  • Other

Impaired placentation

  1. A comparative analysis of estimated fetal weight and birthweight View pdf
  2. A novel approach for first-trimester uterine artery Doppler assessment: the transverse technique View pdf
  3. A randomised controlled trial of sildenafil therapy in dismal prognosis early-onset intrauterine growth restriction View pdf
  4. Accuracy of second trimester prediction of preterm preeclampsia by three different screening algorithms View pdf
  5. Assessment of epicardial fat and carotid intima media thickness in gestational hypertension View pdf
  6. Birthweight, intra-uterine fetal growth pattern and feto-placental Dopplers of pregnancies following bariatric surgery View pdf
  7. Calcium to creatinine ratio in prediction of pre-eclampsia. View pdf
  8. Cardiac overload in hypertensive pregnancies View pdf
  9. Chasing novel biomarkers to predict preterm and term preeclampsia View pdf
  10. Chorioangioma associated with preeclampsia View pdf
  11. Clinical and laboratory findings in women with preeclampsia in the perinatal period View pdf
  12. Combined screening for preeclampsia at 11–13 weeks View pdf
  13. Combined screening for small for gestational age at 11–13 weeks View pdf
  14. Comparison of first and second trimester uterine artery Doppler in predicting preclampsia and low birth weight View pdf
  15. Comparison of three algorithms for prediction of preeclampsia in the first trimester of pregnancy View pdf
  16. Comparison of two test systems for sFlt-1, PlGF and the sFlt-1/PlGF ratio assessment View pdf
  17. Diagnostic accuracy of different sFlt-1 and PlGF cut-off values in the assessment of preterm and term preeclampsia View pdf
  18. Does umbilical coiling index affect mechanisms of placental-fetal blood flow? View pdf
  19. Early prediction of adverse pregnancy outcomes by uterine artery Doppler and cervical length in ART pregnancies View pdf
  20. Effect of different methods for mean arterial pressure measurement on patient-specific risks for PE View pdf
  21. Effectiveness of Fetal Medicine Foundation prediction model (FMF2012) in screening for preeclampsia View pdf
  22. Effects of preeclampsia and peripheral oedema on skeletal muscle oxygenation View pdf
  23. Endothelial function assessment using Peripheral Artery Tone plethysmography during pregnancy View pdf
  24. Fetal lung maturity in preeclamptic and diabetic patients View pdf
  25. First trimester screening for early and late PE using maternal characteristics, biomarkers and placental volume View pdf
  26. Frequency of stillbirth and analysis of its causes at MCH Centre FGPC Islamabad Pakistan View pdf
  27. Gestational hypertension markers in patients with metabolic syndrome in first trimester of pregnancy View pdf
  28. Hyperkalaemia and hyponatraemia associated with severe preeclampsia View pdf
  29. Hypertension in pregnancy: prevalence, characteristics, complications, and perinatal outcomes in Thailand View pdf
  30. Hypertensive disorders in pregnancy and BMI View pdf
  31. Hypogastric artery ligation for morbidly adherent placenta View pdf
  32. Impact of aspirin and additional antenatal scans to women with a low PAPP-A View pdf
  33. Increased CD14++CD16-CCR2+ monocyte-platelet aggregates in pregnant women with previous hypertension View pdf
  34. Interval between pregnancies as a risk factor for preeclampsia View pdf
  35. Intraplacental villous artery Doppler as an independent predictor of placental morbidity View pdf
  36. Is forty the new thirty? View pdf
  37. Longitudinal evaluation of fetal growth and placental perfusion in euploid fetuses with isolated CHD View pdf
  38. Lower mean arterial pressure on Mexican population underestimates PE risks View pdf
  39. Maternal and neonatal outcomes in nulliparous women at the extremes of maternal age View pdf
  40. Maternal characteristics of severe preeclampsia cases View pdf
  41. Middle cerebral to umbilical artery Doppler ratio in prediction of neonatal outcome in women with preeclampsia View pdf
  42. PAPP-A and β-hCG in pregnant women after ART procedures and pregnancy complications View pdf
  43. Pemphigoid gestationis and intrauterine growth retardation View pdf
  44. Performance of 1st trimester screening for FGR based on maternal characteristics and biophysical markers View pdf
  45. Perinatal outcomes following conception through assisted reproductive technologies View pdf
  46. Perinatal outcomes in fetal growth restriction according to types of hypertensive disorders in pregnancy View pdf
  47. Perinatal outcomes of preeclamspia in carriers of thrombophilia mutations View pdf
  48. Predective value of soluble fms-like tyrosine kinase-1 and placental growth factor in preeclampsia View pdf
  49. Prediction of adverse prenatal outcome: screening by maternal serum AFP at 11–13 weeks View pdf
  50. Predictive factors of hypertensive disorders during pregnancy in colombian pregnant women View pdf
  51. Predictive value of Doppler velocimetry in fetal outcome post term View pdf
  52. Predictive value of Lipocalin 2 and hyperuricemia on maternal and fetal outcome in pre-eclampsia View pdf
  53. Predictive values of maternal biochemistry and uterine artery Doppler for poor pregnancy outcomes View pdf
  54. Predictors of neonatal outcome in preterm delivery in women with mild preeclampsia View pdf
  55. Preeclampsia prediction in the first trimester of pregnancy View pdf
  56. Pregnancy outcomes in women with low PAPP-A levels View pdf
  57. Pregnancy outcomes in women with positive first-trimester FMF algorithm screening test View pdf
  58. Prospective analysis of MR-proANP in pregnancies with late-onset PE or FGR in the 3rd trimester View pdf
  59. Prospective analysis of sFlt-1/PlGF-Ratio and PAPP-A in late-onset preeclampsia or intrauterine growth restriction View pdf
  60. Quality assessment uterine artery Doppler in the first trimester screening for preeclampsia: Australian experience View pdf
  61. Recurrent placenta-mediated complications in women with three consecutive deliveries View pdf
  62. Role of first trimester fetal growth as screening test for small for gestational age View pdf
  63. Screening for preeclampsia using sFlt-1/PlGF ratio cut-off of 38 at 27-37 weeks gestation View pdf
  64. Serial combined first and third trimester prediction of term preeclampsia: Integrated Proteomics and Metabolomics View pdf
  65. SFlT-1/PlGF monitoring in women with high risk of preeclampsia View pdf
  66. Soluble fms-like tyrosine kinase 1 and placental growth factor in the prediction of preeclampsia View pdf
  67. The effect of pravastatin on fetal and utero-placental blood hemodynamics in early preeclampsia View pdf
  68. The effect of unfavorable intrauterine environment on the renal functional capacity in adulthood: meta-analysis View pdf
  69. The impact of parental biometry, demographics and fetal gender on fetal long bones length View pdf
  70. Trends of uterine artery Doppler in screening for preeclampsia and low birth weight View pdf
  71. Urine protein/creatinine ratio and 24-hour urine collection for the diagnosis of new onset proteinuria View pdf
  72. Volumetric MRI study of the intrauterine growth restriction fetal brain View pdf
172621411899192220052200173217621928221720182161216322811923216619851906204222381848190819782117225722692102222020171761220817862173202318771929212322361777208417652072189417601860199922031867219222391983188119302265223517851960212221211941208619652240198421851944218318472149228220921752
© 2017 The Fetal Medicine Foundation